Ownership stake · Activity not yet classified
Captek Softgel International, Inc.
Transaction overview
Reported completed
Exact closing date not established.
Swander Pace reported closing a continuation-fund transaction that transferred Captek from its Funds V and VI to a new continuation fund, with Morgan Stanley as lead investor and participation from Rabo Investments and reinvesting Swander Pace investors.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Swander Pace Capital Announces First Continuation Fund with Captek Softgel International. Inc. in Partnership with Morgan Stanley and Rabo Investments ↗
Swander Pace Capital · Published Aug 17, 2022
Explicitly reports a closed continuation-fund transaction and acquisition of Captek from SPC Funds V and VI. It does not describe a sale of Swander Pace itself or establish an exact closing date.